ArticleInterdisciplinary cardiovascular and thoracic surgery2026
An Initial Single-Center European Experience with the Gore Thoracic Branch Endoprosthesis.
Article in Interdisciplinary cardiovascular and thoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Management of Left Subclavian Artery in Aortic Open and Endovascular Surgery.Journal of cardiovascular development and disease · 2026Review
- Dedicated Single-Branch Platforms for Totally Endovascular Zone 2 TEVAR with LSA Revascularization: A Comparison of Castor/Cratos and Gore TAG Thoracic Branch Endoprosthesis.Journal of clinical medicine · 2026Review
- Early Outcomes of Zone 2 Thoracic Endovascular Aortic Repair with an Integrated Branch Stent Graft for the Left Subclavian Artery: Evidence from a Western Centre.EJVES vascular forum · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo report an initial experience with a novel off-the-shelf single branched thoracic aortic stent graft preserving various aortic arch vessels.
methodsOur study is a retrospective cohort analysis of the largest European case series to date. We treated twenty patients for various aortic arch and descending pathology in the year 2024 and 2025.
resultsTwenty patients underwent successful implantation of the thoracic branched endoprosthesis (TBE) in the aortic arch and descending thoracic aorta. The sidebranch was applied to preserve the left subclavian artery in 17 patients, the innominate artery in two and the left carotid artery in one patient. Patients were treated for saccular arch aneurysms, chronic type B dissections with progressive dilatation, type 1a endoleaks after TEVAR, degenerative thoracic aneurysms, localized type A dissections or a first stage Crawford type II thoraco-abdominal aneurysm repair followed by a subsequent visceral branched endoprosthesis. The median follow-up period was six (1-12) months and technical results were satisfying. All TBE stentgrafts were implanted in the desired position with a patent branch on computed tomography angiography (CT-A) scan six weeks postoperatively. There was no in-hospital or 30-day mortality. Unfortunately, two patients suddenly died seven and eight weeks postoperatively of unknown causes. CT-A scan at six weeks showed no abnormalities concerning the aorta or TBE in both patients.
conclusionsThe present study demonstrates satisfying technical results with the GORE TBE which was successfully implanted for multiple indications of aortic arch or descending pathology. Longer follow-up and larger series are needed for verification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.